Regeneron collaborates with Truveta to expand a genomic database, investing $119.5 million to enhance genetics-based healthcare research. Regeneron's $119.5 million investment in Truveta's Series C ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a new collaboration with the ...
DANBURY, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Sustainable Development Capital LLP (SDCL) and FuelCell Energy, Inc. (FCEL) (Nasdaq: FCEL) today announced a strategic collaboration to explore the ...